First developed for Canadian patients by WMMC, this Indica-dominant hybrid is rich in the non-psychoactive compound CBG and low in THC. Created by blending a range of strains to achieve a unique cannabinoid profile, it has a fresh, spicy scent with notes of cloves and basil and is designed for patients seeking lower psychoactivity.
CBG is one of the more well-known minor cannabinoids. There is some evidence that CBG may be helpful in reducing pain and inflammation, however, further research to fully examine this in clinical studies is ongoing.
Please note that this product is partially covered for our veteran clients, meaning that Aurora will apply a 25% discount to the list price, prior to direct billing VAC for a maximum of $8.50 per gram. The remaining balance must be paid via an alternative payment method (e.g. credit card).
Reference: Baron EP. Medicinal Properties of Cannabinoids , Terpenes , and Flavonoids in Cannabis , and Benefits in Migraine , Headache , and Pain : An Update on Current Evidence and Cannabis Science. Headache Curr. 2018;58:1139-1186.
You have reached your maximum and cannot add this item.
You have reached your order allowance limit for this product.
You have reached your maximum
You can not add anymore of this product
Your prescription has expired
Unfortunately, the THC or CBD of this product is outside your prescription limits. Please choose another product.
Please speak to your health care provider to get a prescription to be able to purchase this product.